|
- [April 20th, 2009] --- ProtTech introduced flat rate biomarker discovery by proteomics service. Customers will have the flexibility to
choose from labeling their samples with SILAC themselves or
let us label the samples with LIT. [More]
- [April 16th, 2009] --- ProtTech launched online market campaign
to sell monoclonal antibodies including anti-S1P1
mAb, an antibody against cancer target sphingosine
1-phosphate receptor-1. [More]
- [March 1st, 2009] --- ProtTech is
now offering a new service for complete protein profiling.
This service utilized both SDS-PAGE and LCMS/MS and aimed
to identify all the proteins in a complex mixture. [More]
- [November 21st, 2008] --- ProtTech has developed a new technology to determine the complete amino acid
sequence of monoclonal antibodies. Due to its large size and its vast
diversity in antibody sequences, it used to be an extremely difficult task
to carry out the de novo sequencing of such a large protein. Recently, with
the breakthrough we achieved, we are capable to determine the complete
sequence of a mAb with as low as 100 ug sample of some moderate purity
(>85%). ProtTech has started to provide monoclonal antibody de novo sequencing
service based on this new technology. [More]
| |
|